Navigation Links
Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
Date:3/17/2008

Company Receives Initial $3.7 Million Distribution Contract from Anhui

Huayuan Pharmaceutical Co., Ltd.

CHENGDU, China, March 17 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine (''TCM'') based in Chengdu, China, today announced that the Company has been granted SFDA approval and is scheduled to launch Azithromycin Dispersible Tablets in the domestic market on April 15, 2008.

The manufacturing license for Azithromycin Dispersible Tablets is not only the first one Tianyin has received but also the first drug approval SFDA has granted to Sichuan Province in 2008. This is the third generic western medicine to be included in Tianyin's product portfolio. The Company will continue to diversify its TCM products, with additional western medicines as they receive approvals for the 10 drugs that are currently in the SFDA pipeline.

Azithromycin is highly effective in treating upper and lower respiratory tract infections and other bacterial infections in skins and reproductive system. Ever since the drug's first introduction, its sales have been growing steadily. Worldwide sales have grown from US$ 619 million in 1996 to $2.01 billion in 2003, representing a 32.6% growth over the previous year. Azithromycin has become a blockbuster product and is now among the TOP 50 prescription drugs in terms of global sales. It is estimated that approximately $350 million in total Azithromycin sales were generated in China during 2007.

''We are pleased to have the first of our pipeline products approved by the SFDA and believe that the launch of Azithromycin provides the opportunity for significant growth in both sales revenue and net profit in the coming years,'' stated Dr. Guoqing Jiang, Chairman and CEO.

The largest domestic distributor of Azithromycin, Anhui Huayuan Pharmaceutical Co., Ltd. is currently one
'/>"/>

SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Dr. Jes... George Washington University Medical Center in Wa...se of Breast-Specific Gamma Imaging (BSGI) in clin...he diagnosis of breast cancer today at the annual ...ca (RSNA). ,, "The purpose of the exhibit was t...
(Date:11/30/2009)..., , NOVATO, Calif., Nov. 30 /PRNewswire-Firs...MRN ) announced today that the Food and Drug Admin...n for 3,4-diaminopyridine (3,4-DAP), amifampridine...t Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has p...E.U. Also, in October 2009, the Committee for Med...
(Date:11/30/2009)..., , BOSTON and COPENHAGEN, Nov. 30 /PRNew...) announced today that the Harvard Medical School ... recognized as a MicroRNA Screening Center of Exce...Medical School, and associated hospitals and insti...lecule and RNAi libraries. ,, MicroRNAs are a n...
(Date:11/30/2009)..., , AMSTERDAM,...he world,s,leading publisher of scientific, medica...nced a major re-launch of Embase, its comprehensiv...indexed records from more than 7,000,active, peer ...ed a key role in the advancement of new biomedical...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3
...Inc.,(Nasdaq: RDEA ) today announced that data wi...vestigational non-nucleoside reverse transcriptase...eficiency virus (HIV) at,the 48th Annual ICAAC/IDS...,25-28, 2008., Dr. Graeme Moyle, Director of HIV ...resent pharmacokinetic and pharmacodynamic data fr...
...eakers at IMAPS 2008 , Wa...ational Microelectronics and Packaging Society (IM...nd Dr Zolper have agreed to be the Keynote Speaker...croelectronics (IMAPS ,08) at the Providence, RI, ...MAPS ,08 is truly fortunate to have two such disti...
...to drive improvements in customer ...y 28 AMICAS, Inc. (Nasdaq: AMCS ),a leader in ra...nt,solutions, today announced a new partnership wi...nia,s most influential radiology groups., (Logo: ...ASLOGO ), For more than 40 years, Arcadia has pr...
Other Biology Technology:Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 2Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting 3Rhode Island Governor Donald L. Carcieri and Dr. John C. Zolper, Vice President, Raytheon Company to Speak at IMAPS 2008 2Arcadia Radiology Medical Group Chooses AMICAS 2Arcadia Radiology Medical Group Chooses AMICAS 3
(Date:11/25/2009)...ad of the Cell Death Research Laboratory in the Un...n awarded the prestigious Johnson & Johnson Focuse...se of brain cell damage in Parkinson,s disease. Th...in support of innovation and excellence in science...earlier this month at an event at the Hyatt Regenc...
(Date:11/25/2009)...fetime, the heart pumps some 250 million liters of...the muscle fibers of the heart have to be extremel...ng Rottbauer, vice chair of the Department of Medi...an: Prof. Dr. H. A. Katus), has discovered a prote...allest muscular unit, the sarcomere. In cooperatio...
(Date:11/25/2009)...eat may be just as vital to your health as what yo... Biological Studies. Their experiments in mice rev...s of genes in the liverthe body,s metabolic cleari... by the body,s circadian clock as conventional wis...ctivity of a large number of genes completely inde...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Nonsurgical Treatment May Ease Rotator Cuff Injury 50382 1Nonsurgical Treatment May Ease Rotator Cuff Injury 50382 2Nebraska Prescription Assistance Program Launched 50377 1Nebraska Prescription Assistance Program Launched 50377 2Hyperion Therapeutics Raises 2460 Million Series C 50374 1Hyperion Therapeutics Raises 2460 Million Series C 50374 2Hyperion Therapeutics Raises 2460 Million Series C 50374 3
...t Reader to be the Latest Addition to M2SYS, ...TA, Aug. 14 M2SYS Technology, a biometric,technol... its partnership,with SecuGen Corporation to suppo...ter Plus. The Hamster Plus fingerprint reader fea...ally checks for the presence of a finger. The,read...
...eaches 275,000 Enrollment Milestone, NEW YORK, Au... showcase, PerSay, the leader in voice biometrics,... powers Bell,s Voice,Identification Service. Bell,...s made a spoken pass phrase the universal identifi...ts (wireline, wireless, high-speed,Internet, digit...
...ssembly of the six billion base pairs from the gen...zed genomics , Researchers at the J. Craig Venter... Hospital for Sick Children in Toronto and the Uni...shed a genome sequence of an individual, Craig Ven...e inherited from each parent. , Two other versi...
Other Biology News:M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy 2First individual genome sequence published 2First individual genome sequence published 3First individual genome sequence published 4
FluorSave Reagent from Calbiochem
...ured in RPMI 1640 with 2 mM L-glutamine and harves...the antigens in their native forms, cells were fix...a 12-well (5 mm) adhesive coated slide, with each ...ular attachment and to minimize background stainin...
...roteases/caspases initiates apoptosis in mammalian...Detection Kit provides a simple and convenient mea...tometry in intact cells. The assay utilizes a sub... to rhodamine 110 (D2R), a reported substrate for ...
...a premium quality recombinant form of Thermus aqua...suitable for a wide range of PCR applications. To ...ance, each preparation is extensively tested in a ...ymerase possesses an integral 5′→3R...
Biology Products: